Mineralocorticoid Receptor Antagonist Utilization in a Nationally Representative Heart Failure With Reduced Ejection Fraction Outpatient Population: A Cross-Sectional Study
Conclusions:
Although significant data support the use of MRA in HFrEF, utilization is lower than previously estimated.
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Original Investigations Source Type: research
More News: Cardiology | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Heart | Heart Failure | Renal Failure | Study | USA Health